|
|
| Research article summary (published 31 May 2009): |
Reversal of high pancreatic islet and white adipose tissue blood flow in type 2 diabetic GK rats by administration of the beta3-adrenoceptor inhibitor SR-59230A.
Full Abstract
Previous studies have shown that the Goto-Kakizaki (GK) rat, a nonobese type 2 diabetes model, has an increased white adipose tissue (WAT) and islet blood flow when compared with control rats. The aim of the study was to examine if these increased blood flow values in GK rats could be affected by the beta(3)-adrenoceptor antagonist SR-59230A. We measured organ blood flow with a microsphere technique 10 min after administration of SR-59230A (1 mg/kg body wt), or the corresponding volume of 0.9% NaCl solution (1 ml/kg body wt) in rats anaesthetized with thiobutabarbital. The GK rat had an increased blood flow in all intra-abdominal adipose tissue depots except for the sternal fat pad compared with Wistar-Furth (WF) rats. However, no differences were seen in the blood perfusion of subcutaneous white or brown adipose tissue. The blood flow was also increased in both the pancreas and in the islets in the GK rat compared with WF rats. SR-59230A treatment affected neither WAT nor pancreatic blood flow in WF rats. In GK rats, on the other hand, SR-59230A decreased both WAT and islet blood flow values to values similar to those seen in control WF rats. The whole pancreatic blood flow was not affected by SR-59230A administration in GK rats. Interestingly, the brown adipose tissue blood flow in GK rats increased after SR-59230A administration. These results suggest that beta(3)-adrenoceptors are involved in regulation of blood flow both in islet and in adipose tissue.
Author information
Author/s: Pettersson, U S (US); Henriksnäs, J (J); Jansson, L (L);
Affiliation: Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden. ulrika.pettersson(-atsign-)mcb.uu.se
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: American journal of physiology. Endocrinology and metabolism (Am J Physiol Endocrinol Metab), published in United States. (Language: eng)
Reference: 2009-Aug; vol 297 (issue 2) : pp E490-4
Dates: Created 2009/07/23; Completed 2009/08/18;
PMID: 19491297, status: MEDLINE (last retrieved date: 8/21/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Angiogenesis Inhibitors (0) ; Propanolamines (0) ; Receptors, Adrenergic, beta-3 (0) ; SR 59230A (0)Related articles
These are the most related articles currently in our database:
- [Effect of arotinolol on insulin secretion and insulin clearance rate in patients with Graves' disease]
18 Aug 1993 - American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part III.
30 May 2007 - American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part I.
30 May 2007 - Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity.
8 Apr 2008 - Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes.
5 Dec 2007 - Effects of aging on adipose resistance artery vasoconstriction: possible implications for orthostatic blood pressure regulation.
18 Sep 2007 - Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.
25 Jan 2005 - Targeted therapies in the treatment of renal cell carcinoma.
30 Dec 2007 - Small molecule vascular disrupting agents: potential new drugs for cancer treatment.
30 Dec 2006 - Analysis of relative change and initial value in biological studies.
30 Dec 1983
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.